<DOC>
	<DOCNO>NCT01920828</DOCNO>
	<brief_summary>The purpose study learn gait ( walk ) characteristic MPS IVA possible change gait enzyme replacement therapy .</brief_summary>
	<brief_title>Gait Analysis MPS IVA</brief_title>
	<detailed_description>The purpose 3-year study conduct longitudinal investigation use motion analysis gait objectively quantitatively assess gait characteristic MPS IVA patient . Data document gait characteristic abnormality gather patient initiate enzyme replacement therapy . Inclusion criterion Individuals MPS IVA diagnose enzyme molecular study Exclusion Criteria Individual MPS IVA previously enrol BMN-110 Individual non-ambulatory The individual unable complete longitudinal study visit least yearly</detailed_description>
	<mesh_term>Mucopolysaccharidosis IV</mesh_term>
	<mesh_term>Osteochondrodysplasias</mesh_term>
	<criteria>Diagnosis MPS IVA Nonambulatory Previous enrol clinical trial BMN110</criteria>
	<gender>All</gender>
	<minimum_age>1 Year</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2013</verification_date>
</DOC>